For a better user experience please update your browser or use Chrome or Firefox browser.
Utiliidid
Publication detail
HomeCompetition enforcement in the pharmaceutical sector (2009-2017)
European competition authorities working together for affordable and innovative medicines
Selle väljaande uus
number on juba ilmunud
Väljaande metaandmed
Following the European Commission’s inquiry into the pharmaceutical sector in 2009, competition law enforcement and market monitoring in this area have been a high priority across the EU. This report provides an overview of how the Commission and the national competition authorities of the 28 Member States (‘European competition authorities’) have enforced EU antitrust and merger rules in the pharmaceutical sector in 2009-2017. It responds to concerns expressed by the Council and the European Parliament that anti-competitive practices of pharmaceutical companies may endanger patients access to affordable and innovative essential medicines.
- Avaldatud:
- Teemad: Konkurentsipoliitika , Farmaatsia- ja kosmeetikatööstus
- Teema: arstiteaduslik uurimus , ELi konkurentsipoliitika , farmaatsiatööstus , hindade reguleerimine , konkurentsiõigus , ravimikulud , ravimiseadusandlus , turujärelevalve
|
PDF
|
|||
| ISSN | ISBN 978-92-79-98278-1 | DOI 10.2763/218954 | Katalooginumber KD-07-18-081-EN-N |
- Released on EU publications website:
Dokumendivaataja
Note:
Väljaannet ei saa dokumendivaatajas kuvada. Ava veebiversioon
Selle nägemiseks klõpsake nupul „Allalaadimine ja keeled“